文献速递胸部肿瘤

实施淋巴结标本采集套件后肺癌切除术质量的机构层面演变

Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit.
PubMed 文献 · J Thorac Oncol · 2023-03-15

该研究采用机构层面的阶梯楔形实施研究设计,比较实施套件前后机构的肺癌切除质量及同一机构内使用与不使用套件的切除。结果显示实施机构质量优于实施前机构,使用套件病例质量持续高,未使用套件病例质量低,使用套件与未使用套件术后5年总生存率分别为61%与51%。

要点

  • 实施机构与实施前机构相比,未检查淋巴结的aOR为0.62(95%CI 0.49-0.8,p=0.002)。
  • 使用套件病例与未使用套件病例相比,未检查淋巴结的aOR为0.01(95%CI 0.001-0.06,p<0.0001)。
  • 实施机构内使用套件与未使用套件术后5年总生存率分别为61%与51%(p<0.001)。

核心结论

  • 使用淋巴结标本采集套件进行手术改善了机构层面以治愈为目的的肺癌切除质量。

研究设计与样本

  • 采用机构层面的阶梯楔形实施研究设计,比较实施前与实施后机构的肺癌切除质量,并在实施机构内比较未使用与使用套件的切除。
  • 2009年至2020年,3家实施前医院共953例切除;11家实施医院共4013例切除,其中58%未使用套件、42%使用套件。

主要发现

  • 实施机构与实施前机构相比,未检查淋巴结的aOR为0.62(95%CI 0.49-0.8,p=0.002),未检查纵隔淋巴结的aOR为0.56(95%CI 0.47-0.68,p<0.0001),达到美国外科医师学会手术标准5.8的aOR为7.3(95%CI 5.6-9.4,p<0.0001)。
  • 使用套件病例与未使用套件病例相比,未检查淋巴结的aOR为0.01(95%CI 0.001-0.06),未检查纵隔淋巴结的aOR为0.08(95%CI 0.06-0.11),达到手术标准5.8的aOR为11.6(95%CI 9.9-13.7),所有p<0.0001。
  • 实施前机构手术质量持续较差,而实施机构随套件采用而顺序改善;实施机构内使用套件病例质量 uniformly 高,未使用套件病例质量低,接近实施前机构水平。
  • 实施机构内使用套件与未使用套件术后5年总生存率分别为61%与51%(p<0.001)。

关键数值与推荐

  • 质量基准包括未检查淋巴结率、未检查纵隔淋巴结率及达到美国外科医师学会手术标准5.8。
  • 机构层面调整OR(aOR)用于达到质量基准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lung cancer surgery with a lymph node kit improves patient-level outcomes, but institution-level impact is unproven. METHODS: Using an institutional stepped-wedge implementation study design, we compared lung cancer resection quality between institutions in preimplementation and postimplementation phases of kit deployment and, within implementing institutions, resections without versus with the kit. Benchmarks included rates of nonexamination of lymph nodes, nonexamination of mediastinal lymph nodes, and attainment of American College of Surgeons Operative Standard 5.8. We report institution-level adjusted ORs (aORs) for attaining quality benchmarks. RESULTS: From 2009 to 2020, three preimplementing hospitals had 953 resections; 11 implementing hospitals had 4013 resections, 58% without and 42% with the kit. Quality was better in implementing institutions and with kit cases. Compared with preimplementing institutions, the aOR for nonexamination of lymph nodes was 0.62 (0.49-0.8, p = 0.002), nonexamination of mediastinal lymph nodes was 0.56 (0.47-0.68, p < 0.0001), and attainment of Operative Standard 5.8 was 7.3 (5.6-9.4, p < 0.0001); aORs for kit cases were 0.01 (0.001-0.06), 0.08 (0.06-0.11), and 11.6 (9.9-13.7), respectively (p < 0.0001 for all). Surgical quality was persistently poor in preimplementing institutions but sequentially improved in implementing institutions in parallel with kit adoption. In implementing institutions, resections with the kit had a uniformly high level of quality, whereas nonkit cases had a low level of quality, approximating that of preimplementing institutions. Within implementing institutions, 5-year overall survival was 61% versus 51% after surgery with versus without the kit (p < 0.001). CONCLUSIONS: Surgery with a lymph node specimen collection kit improved institution-level quality of curative-intent lung cancer resection.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Akinbobola O, Ray MA, Fehnel C, et al. Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit. J Thorac Oncol. 2023. PMID: 36931504. doi:10.1016/j.jtho.2023.03.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。